Revolution Medicines, Inc. (RVMD)

NMS – Real Time Price. Currency in USD

145.72

+1.57 (1.09%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

12M

35M

Cost of goods sold

-17M

-12M

-9M

-10M

Gross Profit

-17M

-12M

26M

Operating expenses (excl. COGS)

-1.17B

-678M

-489M

-284M

Operating Income

-1.18B

-690M

-487M

-258M

Non-operating income, total

51M

89M

47M

Pretax income

-1.13B

-601M

-440M

-249M

Equity in earnings

Taxes

753K

420K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-1.13B

-600M

-436M

-249M

Revolution Medicines, Inc. (RVMD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Revolution Medicines, Inc. (RVMD)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Revolution Medicines, Inc. (RVMD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Revolution Medicines, Inc. (RVMD)

Income Statement (Annual)

Income Statement (Annual)